Heron Therapeutics announced the appointment of Ira Duarte as Chief Financial Officer. Duarte has more than twenty-five years of experience in a variety of finance and accounting positions, including over a decade in the pharma industry. “I am excited to welcome Ira to Heron as Chief Financial Officer,” said Craig Collard, Chief Executive Officer of Heron. “I had the pleasure of previously working with Ira and I look forward to her contributions as we continue to develop long-term plans aimed at maximizing the potential of Heron’s commercial portfolio.”
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HRTX:
- Heron Therapeutics names William Forbes, Pharm.D. as Chief Development Officer
- Biotech Alert: Searches spiking for these stocks today
- Disastrous Earnings Report Takes Down Heron Therapeutics
- Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2023 and Highlights Recent Corporate Updates
- HRTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?